Influence of health warnings on the use of rosiglitazone and pioglitazone in an area of Spain: A time-series study

BACKGROUND: Throughout 2007 and January 2008, several glitazones health warnings were published on rosiglitazone myocardial infarction risk. The impact of such warnings on glitazones prevalence of utilization has been extensively studied in the United States but only in one European country (England...

Descripción completa

Detalles Bibliográficos
Autores principales: Carracedo-Martínez, Eduardo, Pia-Morandeira, Agustin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2016
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4989582/
https://www.ncbi.nlm.nih.gov/pubmed/27579167
http://dx.doi.org/10.1177/2050312116653054

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4989582/
https://www.ncbi.nlm.nih.gov/pubmed/27579167
http://dx.doi.org/10.1177/2050312116653054

Ejemplares similares